Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma.

导出原文传递

翻译打印收藏纠错

第一作者： Luciano J,Costa

第一单位： University of Alabama at Birmingham, Birmingham, AL, USA.

作者： Luciano J,Costa ^[1] ; Parameswaran,Hari ^[2] ; Jesus G,Berdeja ^[3] ; Valerio,De Stefano ^[4] ; Francesca,Gay ^[5] ; Becky,Hooper ^[6] ; Meaghan,Bartlett ^[6] ; Anja,Haltner ^[6] ; Emily,Rosta ^[6] ; Shaji,Kumar ^[7] ; Thomas,Martin ^[8] ; Maria-Victoria,Mateos ^[9] ; Philippe,Moreau ^[10] ; Saad Z,Usmani ^[11] ; Yunsi,Olyslager ^[12] ; Jordan M,Schecter ^[13] ; Tito,Roccia ^[13] ; Ashraf,Garrett ^[14] ; Sam,Lee ^[14] ; Tonia,Nesheiwat ^[14] ; Lida,Pacaud ^[14] ; Changwei,Zhou ^[14] ; Imtiaz A,Samjoo ^[15] ; Yi,Lin ^[7] ; Joris,Diels ^[12] ; Satish,Valluri ^[16] ; Katja,Weisel ^[17]

作者单位： University of Alabama at Birmingham, Birmingham, AL, USA. ^[1] Iovance Biotherapeutics, San Carlos, CA, USA. ^[2] Sarah Cannon Research Institute, Nashville, TN, USA. ^[3] Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A Gemelli, IRCCS, Rome, Italy. ^[4] Division of Hematology, University of Torino, Torino, Italy. ^[5] EVERSANA, Sydney, NS, Canada. ^[6] Mayo Clinic, Rochester, MN, USA. ^[7] UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. ^[8] Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain. ^[9] Clinical Hematology, University Hospital Hotel-Dieu, Nantes, France. ^[10] Levine Cancer Institute-Atrium Health, Charlotte, NC, USA. ^[11] Janssen Pharmaceutica NV, Beerse, Belgium. ^[12] Janssen R&D, Raritan, NJ, USA. ^[13] Legend Biotech USA, Piscataway, NJ, USA. ^[14] EVERSANA, Burlington, ON, Canada. ^[15] Janssen Global Services, LLC, Raritan, NJ, USA. ^[16] University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[17]

关键词 CAR-T CARTITUDE-1 Relapsed or refractory multiple myeloma ciltacabtagene autoleucel meta-analysis triple-class exposed

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);人类(Humans);多发性骨髓瘤(Multiple Myeloma);医师(Physicians)

DOI 10.1080/03007995.2022.2100651

PMID 35815818

发布时间 2022-12-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交